• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

消除宫颈癌的投资理由。

The investment case for cervical cancer elimination.

作者信息

Tsu Vivien Davis, Ginsburg Ophira

机构信息

PATH, Seattle, WA, USA.

Department of Population Health, NYU School of Medicine, Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA.

出版信息

Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:69-73. doi: 10.1002/ijgo.12193.

DOI:10.1002/ijgo.12193
PMID:28691328
Abstract

We already know what causes cervical cancer, how to prevent it, and how to treat it, even in resource-constrained settings. Inequitable access to human papillomavirus vaccine for girls and screening and precancer treatment for women in low- and middle-income countries is unacceptable on ethical, social, and financial grounds. The burden of cervical cancer falls on the poor and extends beyond the narrow bounds of the family, affecting national economic development and community life, as family resources are drained and poverty tightens its grip. Proven solutions are available and the priorities for the next few years are clear, as shown by the papers in this Supplement. Sustained political commitment and strategic investments in cervical cancer prevention can not only save millions of lives over the next 10 years, but can also pave the way for the broader fight against all cancers.

摘要

我们已经知道宫颈癌的病因、预防方法以及治疗手段,即便在资源有限的环境下亦是如此。从伦理、社会和经济角度来看,低收入和中等收入国家的女孩无法公平获取人乳头瘤病毒疫苗,以及妇女无法公平获得筛查和癌前病变治疗,这是不可接受的。宫颈癌的负担落在穷人身上,且其影响范围超出了家庭的狭小范畴,随着家庭资源被耗尽以及贫困加剧,这会影响国家经济发展和社区生活。正如本增刊中的论文所示,已证实的解决方案是可行的,未来几年的优先事项也很明确。对宫颈癌预防工作持续投入政治承诺并进行战略投资,不仅能在未来10年挽救数百万人的生命,还能为更广泛的抗癌斗争铺平道路。

相似文献

1
The investment case for cervical cancer elimination.消除宫颈癌的投资理由。
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:69-73. doi: 10.1002/ijgo.12193.
2
The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.在50个低收入和中低收入国家扩大宫颈癌预防工作对健康和经济的影响。
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:47-56. doi: 10.1002/ijgo.12184.
3
Ending cervical cancer: A call to action.终结宫颈癌:行动呼吁。
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:4-6. doi: 10.1002/ijgo.12182.
4
Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).基于模型的中东北非延伸地区(EMENA)宫颈癌预防的影响和成本效益。
Vaccine. 2013 Dec 30;31 Suppl 6:G65-77. doi: 10.1016/j.vaccine.2012.06.096.
5
What works for human papillomavirus vaccine introduction in low and middle-income countries?在低收入和中等收入国家引入人乳头瘤病毒疫苗,有哪些可行的做法?
Papillomavirus Res. 2017 Dec;4:22-25. doi: 10.1016/j.pvr.2017.06.003. Epub 2017 Jun 8.
6
An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.中国公共财政资助的人乳头瘤病毒(HPV)疫苗预防宫颈癌的扩展成本效益分析
Vaccine. 2015 Jun 4;33(24):2830-41. doi: 10.1016/j.vaccine.2015.02.052. Epub 2015 Mar 12.
7
Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.中东欧和中亚宫颈癌预防的成本效益。
Vaccine. 2013 Dec 31;31 Suppl 7:H71-9. doi: 10.1016/j.vaccine.2013.04.086.
8
Global elimination of cervical cancer is achievable-with commitment.全球消除宫颈癌是可以实现的——只要有决心。
Lancet Oncol. 2019 Nov;20(11):1467. doi: 10.1016/S1470-2045(19)30647-3.
9
Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.在洪都拉斯引入人乳头瘤病毒疫苗的成本效益分析。
Vaccine. 2015 May 7;33 Suppl 1:A167-73. doi: 10.1016/j.vaccine.2014.12.067.
10
Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.在巴西将11岁女孩的人乳头瘤病毒普遍疫苗接种纳入国家免疫规划的成本效益分析。
Vaccine. 2015 May 7;33 Suppl 1:A135-42. doi: 10.1016/j.vaccine.2014.12.031.

引用本文的文献

1
Barriers and facilitators to implementation of the Ethiopian national cancer control plan strategies: Implications for cervical cancer services in Ethiopia.埃塞俄比亚国家癌症控制计划策略实施的障碍与促进因素:对埃塞俄比亚宫颈癌服务的启示
PLOS Glob Public Health. 2024 Jul 22;4(7):e0003500. doi: 10.1371/journal.pgph.0003500. eCollection 2024.
2
The levels of women's awareness, experience, acceptability and preference for Vaginal Human Papillomavirus (HPV) self-sampling in three provinces of China: a cross-sectional study.中国三个省份女性对阴道人乳头瘤病毒(HPV)自我采样的知晓率、经验、可接受性和偏好程度的横断面研究。
BMC Womens Health. 2024 Jun 15;24(1):343. doi: 10.1186/s12905-024-03186-w.
3
Smartphone-Enhanced Training, QA, Monitoring, and Evaluation of a Platform for Secondary Prevention of Cervical Cancer: Opportunities and Challenges to Implementation in Tanzania.
智能手机强化的宫颈癌二级预防平台培训、质量保证、监测与评估:坦桑尼亚实施中的机遇与挑战
JCO Glob Oncol. 2020 Jul;6:1114-1123. doi: 10.1200/GO.20.00124.
4
Assessing an intervention to increase knowledge related to cervical cancer and the HPV vaccine.评估一项旨在提高与宫颈癌和 HPV 疫苗相关知识的干预措施。
Adv Cancer Res. 2020;146:115-137. doi: 10.1016/bs.acr.2020.01.007. Epub 2020 Mar 12.
5
A study on service capacity of primary medical and health institutions for cervical cancer screening in urban and rural areas in China.中国城乡基层医疗卫生机构宫颈癌筛查服务能力研究
Chin J Cancer Res. 2019 Oct;31(5):838-848. doi: 10.21147/j.issn.1000-9604.2019.05.13.
6
Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.将世界卫生组织推荐的非传染性疾病基本药物列入国家基本药物清单的选择。
PLoS One. 2019 Aug 9;14(8):e0220781. doi: 10.1371/journal.pone.0220781. eCollection 2019.
7
Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.马拉维松巴中央医院将宫颈癌筛查与治疗纳入艾滋病服务的早期经验。
Malawi Med J. 2018 Sep;30(3):211-214. doi: 10.4314/mmj.v30i3.14.
8
Manifesto for global women's health.全球女性健康宣言。
Nat Rev Clin Oncol. 2018 Jan;15(1):3-4. doi: 10.1038/nrclinonc.2017.150. Epub 2017 Sep 12.